AU1204976A - Sustained release formulation - Google Patents

Sustained release formulation

Info

Publication number
AU1204976A
AU1204976A AU12049/76A AU1204976A AU1204976A AU 1204976 A AU1204976 A AU 1204976A AU 12049/76 A AU12049/76 A AU 12049/76A AU 1204976 A AU1204976 A AU 1204976A AU 1204976 A AU1204976 A AU 1204976A
Authority
AU
Australia
Prior art keywords
sustained release
release formulation
formulation
sustained
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU12049/76A
Other versions
AU505355B2 (en
Inventor
P. R. Tossounian J. L Sheth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority claimed from KR7600645A external-priority patent/KR800001387B1/en
Publication of AU1204976A publication Critical patent/AU1204976A/en
Application granted granted Critical
Publication of AU505355B2 publication Critical patent/AU505355B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
AU12049/76A 1975-03-17 1976-03-16 Sustained release formulation Expired AU505355B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
USUS559,107 1975-03-17
US65800376A 1976-02-13 1976-02-13
USUS658,003 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (2)

Publication Number Publication Date
AU1204976A true AU1204976A (en) 1977-09-22
AU505355B2 AU505355B2 (en) 1979-11-15

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12049/76A Expired AU505355B2 (en) 1975-03-17 1976-03-16 Sustained release formulation

Country Status (21)

Country Link
JP (1) JPS51115910A (en)
AR (1) AR222624A1 (en)
AT (1) AT353415B (en)
AU (1) AU505355B2 (en)
CA (1) CA1073358A (en)
CH (1) CH630257A5 (en)
DD (1) DD124102A5 (en)
DE (1) DE2611041A1 (en)
DK (1) DK148344C (en)
ES (1) ES446075A1 (en)
FR (1) FR2304354A1 (en)
GB (1) GB1546448A (en)
GR (1) GR60341B (en)
IE (1) IE43083B1 (en)
LU (1) LU74558A1 (en)
MC (1) MC1101A1 (en)
NL (1) NL190313C (en)
NZ (1) NZ180321A (en)
PH (1) PH14927A (en)
PT (1) PT64907B (en)
SE (1) SE433804B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692483B2 (en) * 1993-10-29 1998-06-11 R.P. Scherer Corporation Gelatin capsule fill able to foam

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (en) * 1981-04-29 1985-05-15 Hoffmann La Roche PHARMACEUTICAL PREPARATIONS.
CH652025A5 (en) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmaceutical preparation.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
CH666406A5 (en) * 1984-02-29 1988-07-29 Sandoz Ag METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (en) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション sustained release pharmaceutical capsules
JPS6143108A (en) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd Medicinal drug and its preparation
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (en) * 1985-10-01 2003-04-03 Novartis Ag Preparation for oral administration with controlled release and method for its preparation.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
SK282072B6 (en) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Water-dispersible tablet containing lamotrigine and its preparation method
WO1992017166A1 (en) * 1991-04-08 1992-10-15 Nippon Shinyaku Co., Ltd. Capsule
ATE173159T1 (en) * 1992-03-25 1998-11-15 Depomed Systems Inc ORAL MEDICINAL DOSAGE FORMS BASED ON HYDROXYETHYL CELLULOSE WITH DELAYED RELEASE
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
JPH09504286A (en) * 1993-10-29 1997-04-28 レキット アンド コールマン プロダクツ リミテッド Effervescent gelatin capsule filling
NZ287277A (en) * 1994-05-13 1998-05-27 Smithkline Beecham Corp Oral preparation containing calcium source within a hydrophilic polymer matrix for increasing calcium absorption in the stomach
WO1996016638A1 (en) * 1994-12-01 1996-06-06 Cibus Pharmaceutical, Inc. Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants
FR2820318B1 (en) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals METHOD FOR MANUFACTURING A FLOATING COMPRESSOR INCLUDING AN ACTIVE INGREDIENT AND A COMPRESS OBTAINED
FR2820319B3 (en) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals PROCESS FOR PRODUCING A FLOATING TABLET INCLUDING ALFUZOSINE AND TABLET OBTAINED
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (en) * 2004-08-19 2006-10-20 Sanofi Synthelabo PHARMACEUTICAL COMPOSITION IN THE FORM OF A GASTRIC RESISTANCE COMPRESSOR CONTAINING ALFUZOSIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (en) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Process for the production of medicaments dispersed in a carrier substance in dosed form
JPS5512411B2 (en) * 1974-03-12 1980-04-02
DE2439538C3 (en) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Process for the manufacture of orally administered drugs with delayed release of action

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692483B2 (en) * 1993-10-29 1998-06-11 R.P. Scherer Corporation Gelatin capsule fill able to foam

Also Published As

Publication number Publication date
DK113676A (en) 1976-09-18
NL7602776A (en) 1976-09-21
CH630257A5 (en) 1982-06-15
NL190313B (en) 1993-08-16
MC1101A1 (en) 1977-02-04
GR60341B (en) 1978-05-17
NZ180321A (en) 1978-06-20
IE43083B1 (en) 1980-12-17
DD124102A5 (en) 1977-02-02
PT64907A (en) 1976-04-01
DE2611041C2 (en) 1988-06-09
AR222624A1 (en) 1981-06-15
DK148344B (en) 1985-06-17
AU505355B2 (en) 1979-11-15
NL190313C (en) 1994-01-17
JPS638084B2 (en) 1988-02-19
IE43083L (en) 1976-09-17
AT353415B (en) 1979-11-12
CA1073358A (en) 1980-03-11
DE2611041A1 (en) 1976-10-14
GB1546448A (en) 1979-05-23
PT64907B (en) 1978-03-24
DK148344C (en) 1985-11-04
ATA192276A (en) 1979-04-15
FR2304354A1 (en) 1976-10-15
LU74558A1 (en) 1977-09-27
SE7603325L (en) 1976-09-18
SE433804B (en) 1984-06-18
PH14927A (en) 1982-01-29
FR2304354B1 (en) 1979-04-27
ES446075A1 (en) 1977-09-16
JPS51115910A (en) 1976-10-13

Similar Documents

Publication Publication Date Title
AU505355B2 (en) Sustained release formulation
AU498744B2 (en) Release agent
AU508266B2 (en) Controlled release preparations
AU500958B2 (en) Shoe-sole configuration
AU497066B2 (en) Photocoplymerizable composition
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU1441776A (en) Thieno-pyridines
AU1373876A (en) Bottlecap
AU500738B2 (en) Preparation
AU497446B2 (en) Composition
AU1128976A (en) Magneto-alternator
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
CA1020668A (en) Tritium-in-air monitor
AU511364B2 (en) Absorption-refrigerant composition
AU1408076A (en) Lysolipin Antibioties
AU1191776A (en) Fluoro-prostaglandins
AU497193B2 (en) Sprinkler
AU505910B2 (en) Neamatocidal composition
AU1393076A (en) Dihydromocimycin
ZA761305B (en) Sustained release formulation
AU1398876A (en) Aryl-di-thioureas